Viewing StudyNCT00165217



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00165217
Status: COMPLETED
Last Update Posted: 2007-12-21
First Post: 2005-09-09

Brief Title: Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 01-141
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Massachusetts General Hospital OTHER
Brigham and Womens Hospital OTHER